- Home
- CNOB vs ATRC Comparison
CNOB vs ATRC Comparison
Compare CNOB & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNOB
- ATRC
- Stock Information
- Founded
- CNOB 1982
- ATRC 2000
- Country
- CNOB United States
- ATRC United States
- Employees
- CNOB N/A
- ATRC N/A
- Industry
- CNOB Major Banks
- ATRC Medical/Dental Instruments
- Sector
- CNOB Finance
- ATRC Health Care
- Exchange
- CNOB Nasdaq
- ATRC Nasdaq
- Market Cap
- CNOB 928.9M
- ATRC 1.1B
- IPO Year
- CNOB 1996
- ATRC 2005
- Fundamental
- Price
- CNOB $27.09
- ATRC $35.03
- Analyst Decision
- CNOB Buy
- ATRC Strong Buy
- Analyst Count
- CNOB 4
- ATRC 9
- Target Price
- CNOB $26.50
- ATRC $43.11
- AVG Volume (30 Days)
- CNOB 243.6K
- ATRC 728.7K
- Earning Date
- CNOB 10-24-2024
- ATRC 10-29-2024
- Dividend Yield
- CNOB 2.66%
- ATRC N/A
- EPS Growth
- CNOB N/A
- ATRC N/A
- EPS
- CNOB 1.73
- ATRC N/A
- Revenue
- CNOB $248,641,000.00
- ATRC $447,573,000.00
- Revenue This Year
- CNOB N/A
- ATRC $17.75
- Revenue Next Year
- CNOB $35.98
- ATRC $13.44
- P/E Ratio
- CNOB $15.66
- ATRC N/A
- Revenue Growth
- CNOB N/A
- ATRC 17.56
- 52 Week Low
- CNOB $17.07
- ATRC $18.94
- 52 Week High
- CNOB $29.02
- ATRC $43.00
- Technical
- Relative Strength Index (RSI)
- CNOB 56.00
- ATRC 60.08
- Support Level
- CNOB $26.71
- ATRC $33.08
- Resistance Level
- CNOB $29.02
- ATRC $38.34
- Average True Range (ATR)
- CNOB 0.91
- ATRC 1.47
- MACD
- CNOB 0.19
- ATRC -0.01
- Stochastic Oscillator
- CNOB 63.24
- ATRC 67.13
About CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a holding company. The company through its holding provides banking services including lending, depository, and related financial services to commercial, industrial and governmental customers. It is managed as one segment: a community bank. It generates revenue from net interest income.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.